Back to search

France· FR:63314092

ELOCTA 4000 UI, poudre et solvant pour solution injectable

A efmoroctocog alfa product containing efmoroctocog alfa, registered in France by SWEDISH ORPHAN BIOVITRUM INTERNATIONAL (SUEDE). The same ATC class is registered in 3 of our 19 countries.

ATC B02BD32

Checked against Base de données publique des médicaments — BDPM (France) on

Informational only — not a medical device.

SOURCE REGISTER · FRBase de données publique des médicament…normalisedELOCTA 4000 UI, poudre et solvant pou…ATCB02BD32REGISTER NO.FR:63314092PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Efmoroctocog alfa is registered in 3 of 19 countries.

Countries holding a registration under ATC B02BD32 (efmoroctocog alfa), each read from that country’s own register.

  • This record: France, from Base de données publique des médicaments — BDPM (France)
  • 2 of them publish a price we can compare per daily dose

Efmoroctocog alfa · ATC B02BD32

3 / 19 countries

  • Franceprice
  • Italyprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Base de données publique des médicaments — BDPM (France)
Active substance
EFMOROCTOCOG ALFA
Manufacturer
SWEDISH ORPHAN BIOVITRUM INTERNATIONAL (SUEDE)
Country
France (FR)
ATC code
B02BD32
ATC class
Efmoroctocog alfa
Defined daily dose
1 TSD, E
Reimbursed
No
Source register
Base de données publique des médicaments — BDPM (France)
Last checked
September 12, 2026

Packs & prices · 1

  • cip13
    3400955062684
    1 flacon de poudre en verre - 1 seringue préremplie en verre de 3 mL avec piston et adaptateur pour flacon avec set de perfusion avec 2 tampons alcoolisés avec 2 pansements et 1 compresse de gaz

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f5550652-49f3-4f4a-92ed-8bc19ed95bc4
GET /v1/drugs/f5550652-49f3-4f4a-92ed-8bc19ed95bc4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cis": "63314092",
  "date_amm": "2018-12-07",
  "type_amm": "Procédure centralisée",
  "numero_ue": "EU/1/15/1046",
  "substance": "EFMOROCTOCOG ALFA",
  "atc_source": "fr_atc_restore_2026-09-06",
  "statut_amm": "Autorisation active",
  "statut_bdm": null,
  "forme_pharmaceutique": "poudre et  solvant pour solution injectable",
  "voies_administration": "intraveineuse",
  "etat_commercialisation": "Commercialisée",
  "surveillance_renforcee": "Non"
}

See everything about efmoroctocog alfa.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.